• Philanthropy Carousel
    Applications for OMRF's 2015-16 Teen Leaders in Philanthropy program are due Mar. 2!
  • FluNews2
    With the flu seemingly making everyone sick and this year's shot not overly effective, what should you do?
  • Mcever-Xia journals-630x320_ImmunityBoosters
    Two OMRF scientists have been published in prestigious journals after new findings in inflammation and blood vessel function.
  • biorepository-630×320
    OMRF’s biorepository is the largest facility of its kind at a nonprofit and it makes the weather outside feel downright balmy.
  • genome-instability-630×320
    Join us for the Emerging Topics in Genome Instability Symposium April 9-10, 2015. Abstract and registration deadline is Feb. 20. Click for more information, including a list of invited speakers and other details.
  • hepatitis-630×320
    Dr. Stephen Prescott: Express Scripts made the newly approved treatment from AbbVie the exclusive option for patients who suffer from the most prevalent form of hepatitis C (known as genotype 1). Express Scripts has done what the U.S. government couldn’t: It has started a price war.
  • Esmon AHA award-630×320
    Charles Esmon was honored by the American Heart Association as a 2014 Distinguished Scientist.
  • fleming-aprelease
    Applications for OMRF's one-of-a-kind Fleming Scholar Program are due Feb. 2. High school seniors and college freshmen, sophomores and juniors are eligible to apply. Get an up-close and personal look at research. Don't miss it!
MS Center MS Center of Excellence

We’re combining patient care with research to find better ways to treat multiple sclerosis.

Jobs Jobs

OMRF has been named one of Oklahoma’s Best Places to Work. Search our job listings here.

Disease Research Disease Research

Our scientists focus on critical research areas like heart disease, cancer, lupus and Alzheimer’s disease.